Clinical Trial Update: FTS Study in Patients With Advanced Hematologic Malignancies [Phase 1]

View source ↗

Summary

Phase I study update of FTS in patients with advanced hematologic malignancies, including myelodysplastic syndromes and leukemia; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• FTS

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelodysplastic Syndrome, Leukemia | Phase 1 | Status: COMPLETED